Early Precise Identification and Intervention Strategies for Individuals at High Risk of Prediabetes
Sponsor: Peking Union Medical College Hospital
Trial Details
| Condition | Prediabetes |
| Status | Not_yet_recruiting |
| Participants | 1,000 |
| Est. Completion | 31 Dec 2027 |
| Last Updated | 15 Apr 2026 |
Primary Outcome
oral glucose tolerance test
Eligibility Criteria
Inclusion Criteria
Inclusion Criteria: * Voluntarily participate in this study, sign a written informed consent form, and be able to adhere to the study protocol for regular follow-up visits; * Age≥35 years and Chinese Diabetes Risk Score≥25 points (i.e., individuals at high risk for diabetes based on traditional factors); ③Normal blood glucose levels at baseline, as determined by fasting blood glucose, HbA1c, or OGTT testing (i.e., fasting blood glucose \< 6.1 mmol/L AND HbA1c \< 5.7% AND 2-hour OGTT glucose \< 7.8 mmol/L). Exclusion Criteria: * Diagnosed with diabetes or prediabetes: History of diabetes or meeting diagnostic criteria for diabetes at baseline screening (fasting blood glucose ≥7.0 mmol/L or HbA1c ≥6.5%) or prediabetes criteria (i.e., impaired fasting glucose: 6.1-6.9 mmol/L; and/or impaired glucose tolerance: 7.8-11.0 mmol/L; and/or HbA1c 5.7%-6.5%); * Conditions severely affecting blood glucose control: severe cardiac, hepatic, or renal insufficiency (e.g., NYHA Class III-IV heart failure, cirrhosis, renal failure with eGFR \<30 mL/min/1.73 m²); * Severe complications or comorbidities: recent (within 6 months) macrovascular events (e.g., myocardial infarction, stroke); * Malignancy currently active or undergoing treatment; * Severe psychiatric or cognitive impairment preventing study compliance; * Pregnant women, lactating women, or women planning pregnancy within the next year; ⑦ Severe allergy or intolerance to the CGM sensor patch; ⑧ Plans to relocate outside the study center's coverage area within the next year, preventing completion of follow-up; ⑨ Inability or unwillingness to use a smartphone or smart device, which would impair data collection.
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service